Clinical Trials Browser

Phase 2 × Not yet recruiting × ribociclib × Clear all

NCT06849947 2025-12-24

Fulvestrant With Ribociclib Versus Physician's Choice Treatments Recurred After Completion of Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in HR+, HER2- Metastatic Breast Cancer

Phase 2 Not yet recruiting

Breast Cancer Metastatic

NCT07195227 2025-10-02

CADILLAC

Phase 2 Not yet recruiting

Breast Neoplasms